News Headlines

  1. Meet Avance Clinical At BIO Asia-Taiwan 2025 7/15/2025

    This year’s program features Business Partnering, Exhibitions, and Conferences, offering insights into emerging bio-health trends, technologies, and global expansion strategies. Our team is looking forward to connecting with biotech leaders in Taiwan to discuss tailored solutions across the drug development lifecycle.

  2. Part Of $1 Billion Investment Strategy, PCI Pharma Services Completes Acquisition Of Ajinomoto Althea, Enhancing U.S. Drug Product Manufacturing For Aseptic Filling Of Prefilled Syringes & Cartridges 7/9/2025

    The acquisition furthers recent growth in sterile fill/finish, advanced drug delivery systems like prefilled syringes and cartridges, and biologics – including high potent assets for antibody-drug conjugates.

  3. Suvoda And Greenphire Announce Completion of Merger 7/9/2025

     Suvoda and Greenphire have announced the successful completion of their previously announced merger. Through this merger, the combined company is now better equipped to provide a comprehensive solution to its customers to support the urgent and mission critical moments of their clinical trials.

  4. Novotech Showcased In Global Biotech Series For Innovation In Hepatitis B Research 7/8/2025

    Novotech a globally recognized full-service clinical research organization (CRO) and scientific advisory company, is featured in The Next Frontier, a global branded series presented by the Biotechnology Innovation Organization (BIO) and produced by BBC StoryWorks Commercial Productions.

  5. ActiGraph Is Rebranding As Ametris 7/7/2025

    ActiGraph has rebranded to Ametris to reflect its expanded data and technology platform, marking a new chapter in data-driven drug development and digital evidence generation.

  6. ISPOR Takes Health Research Mainstream With Plain Language Summaries 6/30/2025

    ISPOR launches its Plain Language Summaries program, an extension of their efforts to make health economics and outcomes research (HEOR) more accessible to patients, caregivers, and the general public.

  7. Cutting-Edge Innovation Steals Spotlight On London Biotechnology Show 2025 Exhibition Floor 6/27/2025

    The London Biotechnology Show 2025 exhibition floor was a vibrant epicentre of innovation, featuring nearly 100 exhibiting companies representing the entire biotechnology value chain—from laboratory equipment and health tech to compliance and logistics.

  8. Nanoform Starts Pivotal Human Bioequivalence Studies Of Nanoenzalutamide 6/12/2025

    Nanoform Finland Plc, the medicine performance-enhancing company, today announced that it had started pivotal relative bioequivalence studies of Nanoenzalutamide, the nanocrystalline-enabled enzalutamide tablet formulation, a potential alternative to the amorphous solid dispersion (ASD) used in XTANDI® (enzalutamide) [1], the number one prescribed androgen receptor inhibitor [2] approved to treat prostate cancer.

  9. Australia Delivers Certainty For US Biotechs In 2025: Avance Clinical Offers Fast Start-Up, Regulatory Predictability, And R&D Rebates 5/28/2025

    As regulatory uncertainty grows in the United States, US biotechs are increasingly looking to Australia as a stable and predictable launchpad for early-phase clinical trials. With its globally accepted regulatory framework, accelerated timelines, and 43.5% R&D rebate, Australia offers a compelling advantage — and Avance Clinical, Australia’s leading early-phase specialist CRO, is delivering the GlobalReady solution to help biotechs de-risk, conserve capital and accelerate their programs.

  10. Reduce Complexity For Oncology Sites, Sponsors, Patients, And Caregivers 5/27/2025

    Medable Inc. announced its next-generation digital oncology trial offering specifically designed to reduce operational complexity for sites and sponsors.